Companies›Healthcare›Healthcare›Pharmaceuticals & Biotechnology

ADLINE CHEM LAB LIMITED

Healthcare › Pharmaceuticals & Biotechnology
ThemesSolar Energy· announced

Latest filings

  1. Exemption from Related Party Transaction disclosure under Reg 23(9) · Compliance
  2. Adline Chem Lab files Q2 FY27 demat compliance certificate with BSE · Compliance
  3. Summary of the Proceeding of 38th Annual General Meeting of the Company held on Monday, 28th September, 2026. · Board & Shareholder Meetings
All filings ↓
Ask Nexa about ADLINE CHEM LAB LIMITED

Snapshot

What the business is, and whether it's a good one at a fair price.

A Pharmaceuticals & Biotechnology company listed on BSE, reporting revenue of ₹0 Cr over the trailing twelve months.

Market Cap
₹—
P / E (TTM)
—
EV / EBITDA
—
Div Yield
—
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
n/m·
ROCE · capital employed below zero
ROE n/m · margin —
Leverage
n/m·
Debt / Equity · negative net worth
Net debt ₹1.74 Cr
Revenue FY21→FY26
0.0×▼
Revenue change
₹6 Cr → ₹0 Cr
Where it sits among 185 Pharmaceuticals peersBar = share of peers beaten · tick = industry median · latest reported figures
ROCE#181/182
Profit growth#27/158

Scorecard

Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice

Strengths
Nothing stands out in the filed numbers.
Concerns
Negative net worth — liabilities exceed assets by ₹1.77 Cr (FY26)
Debt-to-equity and return on equity are not meaningful below zero equity

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from ADLINE CHEM LAB LIMITED's filed financials and exchange disclosures

What does ADLINE CHEM LAB LIMITED do?

ADLINE CHEM LAB LIMITED is a Pharmaceuticals & Biotechnology company listed on BSE.

Is ADLINE CHEM LAB LIMITED profitable?

No. Over the trailing twelve months ADLINE CHEM LAB LIMITED reported a net loss of ₹0.19 Cr with no revenue reported.

Does ADLINE CHEM LAB LIMITED pay a dividend?

Not in the latest reported year — ADLINE CHEM LAB LIMITED's dividend payout for FY26 was nil.

Is ADLINE CHEM LAB LIMITED debt-free?

No. It reported borrowings of ₹1.80 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹1.74 Cr after cash. Its net worth is negative — liabilities exceed assets by ₹1.77 Cr, so a debt-to-equity ratio is not meaningful.

Where can I track ADLINE CHEM LAB LIMITED's announcements?

Every NSE and BSE filing by ADLINE CHEM LAB LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.